Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (Q3)Jun 30, 2025 | (Q4)Mar 31, 2025 | (Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -57.85%34.37M | 10.48M | -86.99%9.48M | 5.64%2.08M | -76.12%1.32M | 508.21%81.54M | 643.46%72.87M | 107.44%1.16M | -49.72%1.97M | 8.00%5.54M |
| Cost of revenue | -55.11%33.74M | 9.52M | -84.88%10.27M | 213.46%5.89M | -86.66%720K | 311.84%75.16M | 1,457.97%67.91M | -100.29%-27K | -37.49%1.88M | 250.23%5.4M |
| Gross profit | -90.15%628K | 956K | -115.89%-788K | -4,333.33%-3.81M | 330.00%602K | 116.69%6.38M | 127.92%4.96M | 104.76%1.19M | -90.11%90K | -96.10%140K |
| Operating expense | -120.27%-13.13M | 373K | -34.63%29.14M | -1,713.12%-50.91M | 23.91%5.18M | -7.12%64.77M | 154.76%44.57M | 831.72%12.87M | -93.07%3.16M | -21.75%4.18M |
| Selling and administrative expenses | ---- | ---- | ---- | ---- | ---- | -9.16%19.46M | ---- | ---- | ---- | ---- |
| -Selling and marketing expense | ---- | ---- | ---- | ---- | ---- | -73.39%33K | ---- | ---- | ---- | ---- |
| -General and administrative expense | ---- | ---- | ---- | ---- | ---- | -8.79%19.42M | ---- | ---- | ---- | ---- |
| Other operating expenses | -10.45%60.17M | --2.78M | -11.99%39.76M | 115.19%8.42M | 23.83%5.8M | 9.28%67.2M | 1,893.84%45.17M | 27.60%13.43M | -91.74%3.91M | -23.36%4.68M |
| Total other operating income | 2,918.99%73.3M | --2.4M | 1,667.05%10.62M | 7,757.75%59.33M | 23.17%622K | -81.57%2.43M | -57.22%601K | -93.80%567K | -59.23%755K | -34.50%505K |
| Operating profit | 123.56%13.76M | 583K | 24.45%-29.92M | 1,636.20%47.1M | -13.30%-4.58M | 45.91%-58.39M | -12.32%-39.61M | 55.65%-11.68M | 93.13%-3.07M | -130.35%-4.04M |
| Net non-operating interest income (expenses) | 36.40%-5.55M | -527K | -22.98%-2.61M | 74.77%-527K | 59.58%-1.08M | 40.94%-8.73M | 77.40%-2.12M | 13.31%-1.84M | -7.96%-2.09M | -102.34%-2.68M |
| Non-operating interest income | ---- | ---- | ---- | ---- | ---- | -60.95%123K | ---- | ---- | ---- | ---- |
| Non-operating interest expense | -36.40%5.55M | --527K | 22.98%2.61M | -74.77%527K | -59.58%1.08M | -35.02%8.73M | -73.62%2.12M | -13.31%1.84M | 7.96%2.09M | 102.34%2.68M |
| Total other finance cost | ---- | ---- | ---- | ---- | ---- | -1.26%1.64M | ---- | ---- | ---- | ---- |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | 38.46%-8K | -1K | -2K | -125.00%-9K | 250.00%6K | 43.48%-13K | 0 | 28.57%-5K | 20.00%-4K | 33.33%-4K |
| Special income (charges) | -24,420.93%-10.46M | |||||||||
| Less:Write off | ---- | ---- | ---- | ---- | ---- | 24,420.93%10.46M | ---- | ---- | ---- | ---- |
| Other non-operating income (expenses) | ||||||||||
| Income before tax | 112.21%8.2M | 55K | 22.03%-32.54M | 1,002.58%46.56M | 15.90%-5.65M | 45.30%-67.13M | 6.48%-41.73M | 52.49%-13.52M | 88.92%-5.16M | -118.01%-6.72M |
| Income tax | 232.24%972K | 400K | -96.44%129K | 680.77%406K | 114.46%35K | -124.98%-735K | 11.96%3.62M | -1,643.93%-4.17M | 194.55%52K | -242K |
| Net income | 110.88%7.23M | -345K | 27.98%-32.67M | 985.78%46.16M | 12.21%-5.69M | 47.16%-66.4M | 5.23%-45.36M | 66.86%-9.35M | 88.79%-5.21M | -110.16%-6.48M |
| Net income continuous operations | 110.88%7.23M | ---345K | 27.98%-32.67M | 985.78%46.16M | 12.21%-5.69M | 47.16%-66.4M | 5.23%-45.36M | 66.86%-9.35M | 88.79%-5.21M | -110.16%-6.48M |
| Noncontrolling interests | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to the company | 110.88%7.23M | -345K | 27.98%-32.67M | 985.78%46.16M | 12.21%-5.69M | 47.16%-66.4M | 5.23%-45.36M | 66.86%-9.35M | 88.79%-5.21M | -110.16%-6.48M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 110.88%7.23M | -345K | 27.98%-32.67M | 985.78%46.16M | 12.21%-5.69M | 47.16%-66.4M | 5.23%-45.36M | 66.86%-9.35M | 88.79%-5.21M | -110.16%-6.48M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 110.85%0.0147 | -0.0007 | 27.89%-0.0667 | 988.68%0.0942 | 12.12%-0.0116 | 47.15%-0.1355 | 5.32%-0.0925 | 66.84%-0.0191 | 88.83%-0.0106 | -109.52%-0.0132 |
| Diluted earnings per share | 110.85%0.0147 | -0.0007 | 27.89%-0.0667 | 988.68%0.0942 | 12.12%-0.0116 | 47.15%-0.1355 | 5.32%-0.0925 | 66.84%-0.0191 | 88.83%-0.0106 | -109.52%-0.0132 |
| Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.